Inflammatory cell-specific transgene expression system responding to Iκ-B kinase beta activation

Journal of Gene Medicine

Volumn 11, Issue 7, 2009, Pages 624-632

  Asai, Daisuke ^a,b   Tsuchiya, Akira ^c   Kang, Jeong Hun ^b,c   Kawamura, Kenji ^c   Oishi, Jun ^c   Mori, Takeshi ^c   Niidome, Takuro ^b,c   Shoji, Yoko ^a,b   Nakashima, Hideki ^a,b   Katayama, Yoshiki ^b,c  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Gene delivery; Gene therapy; IKK ; Inflammation; NF B

Indexed keywords

I KAPPA B KINASE BETA; I KAPPA B KINASE; PEPTIDE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; INFLAMMATORY CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MODULATION; PLASMID; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; TRANSGENE; ANIMAL; CHEMICAL STRUCTURE; ENZYME ACTIVATION; EVALUATION; GENE THERAPY; GENE TRANSFER; GENETICS; INFLAMMATION; METABOLISM; MOUSE;

ANIMALS; ENZYME ACTIVATION; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; I-KAPPA B KINASE; INFLAMMATION; MICE; MOLECULAR STRUCTURE; PEPTIDES; TRANSGENES;

EID: 68949211766     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1342     Document Type: Article

References (35)

1. Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002; 109: (Suppl): S81-S96.
2. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev 2004; 18: 2195-2224.
3. Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol 2002; 3: 221-227.
4. Karin M. Inflammation-activated protein kinases as targets for drug development. Proc Am Thorac Soc 2005; 2: 386-390.
5. McCulloch CA, Downey GP, El-Gabalawy H. Signalling platforms that modulate the inflammatory response: new targets for drug development. Nat Rev Drug Discov 2006; 5: 864-876.
6. Palladino MA, Bahjat FR, Theodorakis EA, et al. Anti-TNF-alpha therapies: the next generation. Nat Rev Drug Discov 2003; 2: 736-746.
7. Smolen JS, Steiner G. Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov 2003; 2: 473-488.
8. Greten FR, Eckmann L, Greten TF, et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004; 118: 285-296.
9. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006; 441: 431-436.
10. Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006; 124: 823-835.
11. Gordge PC, Hulme MJ, Clegg RA, et al. Elevation of protein kinase A and protein kinase C activities in malignant as compared with normal human breast tissue. Eur J Cancer 1996; 32A: 2120-2126.
12. Irby RB, Yeatman TJ. Role of Src expression and activation in human cancer. Oncogene 2000; 19: 5636-5642.
13. Griner EM, Kazanietz MG. Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 2007; 7: 281-294.
14. Delhase M, Li N, Karin M. Kinase regulation in inflammatory response. Nature 2000; 406: 367-368.
15. Greten FR, Arkan MC, Bollrath J, et al. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 2007; 130: 918-931.
16. Kawamura K, Oishi J, Sakakihara S, et al. Intracellular signal-responsive artificial gene regulation. J Drug Target 2006; 14: 456-464.
17. Katayama Y, Fujii K, Ito E, et al. Intracellular signal-responsive artificial gene regulation for novel gene delivery. Biomacromolecules 2002; 3: 905-909.
18. Oishi J, Kawamura K, Kang JH, et al. An intracellular kinase signal-responsive gene carrier for disordered cell-specific gene therapy. J Control Release 2006; 110: 431-436.
19. Oishi J, Ijuin M, Sonoda T, et al. A protein kinase signal-responsive gene carrier modified RGD peptide. Bioorg Med Chem Lett 2006; 16: 5740-5743.
20. Carlson CC, Smithers SL, Yeh KA, et al. Protein kinase A regulatory subunits in colon cancer. Neoplasia 1999; 1: 373-378.
21. Ludwig KW, Lowey B, Niles RM. Retinoic acid increases cyclic AMP-dependent protein kinase activity in murine melanoma cells. J Biol Chem 1980; 255: 5999-6002.
22. Kawamura K, Oishi J, Kang JH, et al. Intracellular signal-responsive gene carrier for cell-specific gene expression. Biomacromolecules 2005; 6: 908-913.
23. Burke JR, Wood MK, Ryseck RP, et al. Peptides corresponding to the N and C termini of IkappaB-alpha, -beta, and -epsilon as probes of the two catalytic subunits of IkappaB kinase, IKK-1 and IKK-2. J Biol Chem 1999; 274: 36146-36152.
24. Kishore N, Huynh QK, Mathialagan S, et al. IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2: comparative analysis of recombinant human IKK-i, TBK-1, and IKK-2. J Biol Chem 2002; 277: 13840-13847.
25. Wisniewski D, LoGrasso P, Calaycay J, et al. Assay for IkappaB kinases using an in vivo biotinylated IkappaB protein substrate. Anal Biochem 1999; 274: 220-228.
26. Karin M. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 1999; 18: 6867-6874.
27. Schomer-Miller B, Higashimoto T, Lee YK, et al. Regulation of IkappaB kinase (IKK) complex by IKKgamma-dependent phosphorylation of the T-loop and C terminus of IKKbeta. J Biol Chem 2006; 281: 15268-15276.
28. Hashida N, Ohguro N, Yamazaki N, et al. High-efficacy site-directed drug delivery system using sialyl-Lewis X conjugated liposome. Exp Eye Res 2008; 86: 138-149.
29. Tan PH, Manunta M, Ardjomand N, et al. Antibody targeted gene transfer to endothelium. J Gene Med 2003; 5: 311-323.
30. Willis M, Forssen E. Ligand-targeted liposomes. Adv Drug Deliv Rev 1998; 29: 249-271.
31. Kang JH, Asai D, Kim JH, et al. Design of polymeric carriers for cancer-specific gene targeting: utilization of abnormal protein kinase Calpha activation in cancer cells. J Am Chem Soc 2008; 130: 14906-14907.
32. Goossens PH, Schouten GJ, t Hart BA, et al. Feasibility of adenovirus-mediated nonsurgical synovectomy in collagen-induced arthritis-affected rhesusmonkeys. Hum Gene Ther 1999; 10: 1139-1149.
33. Robbins PD, Evans CH, Chernajovsky Y. Gene therapy for arthritis. Gene Ther 2003; 10: 902-911.
34. Sant SM, Suarez TM, Moalli MR, et al. Molecular lysis of synovial lining cells by in vivo herpes simplex virus-thymidine kinase gene transfer. Hum Gene Ther 1998; 9: 2735-2743.
35. Evans CH, Ghivizzani SC, Robbins PD. Gene therapy for arthritis: what next? Arthritis Rheum 2006; 54: 1714-1729.